Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The North America biobanks market is expected to register a CAGR of around 6% during the forecast period of 2018–2023. Biobanks are the biorepository where various biomaterials are stored for research purposes. A few decades ago, biobanks were primarily restricted to established economies carrying out breakthrough research in biological sciences. The biobank industry has come a long way since then, with an increasing number of biobanking services and global presence.
Advancements in Stem Cell and Regenerative Medicine Research
Research in regenerative medicine is becoming more intense and advanced in the developed countries, especially in the United States. These advancements in regenerative medicine show considerable potential for disease reversal. Stem cells can treat many hitherto untreatable diseases and are likely to be the therapeutic option for many diseases in the future. Its therapeutic application in the treatment of amyotrophic lateral sclerosis (ALS), Alzheimer's disease, other autoimmune diseases, diabetes, musculoskeletal diseases, ocular diseases, rare genetic diseases, and cancer are being researched through clinical trials. Several of these studies have generated promising results. According to clinicaltrials.gov, currently, there are around 196 studies registered for research on regenerative medicine. The increasing popularity of regenerative medicine research is attracting substantial funding from both public and private investors. This rise in regenerative medicine research has also driven the demand for biobanks, which act as the reservoir for stem cells and other biological samples that are used in regenerative medicine research. The other factors, such as rising incidences of chronic diseases, advances in drug discovery, and R&D funding and investments by government and non-governmental organizations are driving the North American biobanks market.
Regulatory Issues
Biobanks are under ethical oversight from independent reviewers, while the governance process is intended to be public. Oversight may come at the local level, or from an institutional review board, which includes research, particularly medical research. Specific institutional review boards enforce standards set by their respective country’s government. As of now, many countries use laws modeled upon various biobank governance recommendations, which have been proposed internationally. However, there are no internationally accepted set of governance guidelines, which can be designed to work with biobanks. Many existing biobanks typically adapt to the recommendations of guidelines that are accepted for human-subject research and include newer ones, as they are added to the existing guidelines.
The idea of establishing a powerful national population blood-based resource for researchers was first proposed in 1999. Since then, many detailed protocols, ethics, and other government regulations have been developed, while subjecting biobanks to the very highest degree of scrutiny, consultation, and review. However, lack of parity in international set of guidelines has led to regulatory issues in many countries.Some countries have strict regulatory guidelines, which would eventually hinder the growth of the North America biobank market. Therefore, this lack of a defined set of regulations and guidelines, and the irregular regulatory frameworks among the underdeveloped and developing countries are restraining the expansion of the North America biobank market. The other factor, such as cost constraints is also hindering the market.
United States Leads the Market in North America
The United States biobanks market held the largest market share in 2017 in North America due to increasing research in biological sciences, and with huge investments by different pharmaceutical and biotech companies, the utilization of biobanks are increasing consistently.
Key Developments in the Market:
• January 2018: Bio-Techne acquired Atlanta Biologicals Inc.
Major Players: ATLANTA BIOLOGICALS, INC., (BIO-TECHNE), BIOLIFE SOLUTIONS, INC., BIONICHE PHARMA USA LLC, CELL & TISSUE SYSTEMS LLC, ESSENTIAL PHARMACEUTICALS, GENZYME CORPORATION, LIFELINE SCIENTIFIC INC., and SIGMA ALDRICH CORPORATION, among others.
Reasons to Purchase the Report
• Follow the current and future North America biobanks market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s Five Forces Analysis.
• Identify the segment that is expected to dominate the market.
• Identify the regions that are expected to witness the fastest growth during the forecast period.
• Identify the latest developments, market shares, and strategies employed by the major market players.
• 3-month analyst support along with the Market Estimate sheet (in Excel).
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Advancements in Stem Cell and Regenerative Medicine Research
Research in regenerative medicine is becoming more intense and advanced in the developed countries, especially in the United States. These advancements in regenerative medicine show considerable potential for disease reversal. Stem cells can treat many hitherto untreatable diseases and are likely to be the therapeutic option for many diseases in the future. Its therapeutic application in the treatment of amyotrophic lateral sclerosis (ALS), Alzheimer's disease, other autoimmune diseases, diabetes, musculoskeletal diseases, ocular diseases, rare genetic diseases, and cancer are being researched through clinical trials. Several of these studies have generated promising results. According to clinicaltrials.gov, currently, there are around 196 studies registered for research on regenerative medicine. The increasing popularity of regenerative medicine research is attracting substantial funding from both public and private investors. This rise in regenerative medicine research has also driven the demand for biobanks, which act as the reservoir for stem cells and other biological samples that are used in regenerative medicine research. The other factors, such as rising incidences of chronic diseases, advances in drug discovery, and R&D funding and investments by government and non-governmental organizations are driving the North American biobanks market.
Regulatory Issues
Biobanks are under ethical oversight from independent reviewers, while the governance process is intended to be public. Oversight may come at the local level, or from an institutional review board, which includes research, particularly medical research. Specific institutional review boards enforce standards set by their respective country’s government. As of now, many countries use laws modeled upon various biobank governance recommendations, which have been proposed internationally. However, there are no internationally accepted set of governance guidelines, which can be designed to work with biobanks. Many existing biobanks typically adapt to the recommendations of guidelines that are accepted for human-subject research and include newer ones, as they are added to the existing guidelines.
The idea of establishing a powerful national population blood-based resource for researchers was first proposed in 1999. Since then, many detailed protocols, ethics, and other government regulations have been developed, while subjecting biobanks to the very highest degree of scrutiny, consultation, and review. However, lack of parity in international set of guidelines has led to regulatory issues in many countries.Some countries have strict regulatory guidelines, which would eventually hinder the growth of the North America biobank market. Therefore, this lack of a defined set of regulations and guidelines, and the irregular regulatory frameworks among the underdeveloped and developing countries are restraining the expansion of the North America biobank market. The other factor, such as cost constraints is also hindering the market.
United States Leads the Market in North America
The United States biobanks market held the largest market share in 2017 in North America due to increasing research in biological sciences, and with huge investments by different pharmaceutical and biotech companies, the utilization of biobanks are increasing consistently.
Key Developments in the Market:
• January 2018: Bio-Techne acquired Atlanta Biologicals Inc.
Major Players: ATLANTA BIOLOGICALS, INC., (BIO-TECHNE), BIOLIFE SOLUTIONS, INC., BIONICHE PHARMA USA LLC, CELL & TISSUE SYSTEMS LLC, ESSENTIAL PHARMACEUTICALS, GENZYME CORPORATION, LIFELINE SCIENTIFIC INC., and SIGMA ALDRICH CORPORATION, among others.
Reasons to Purchase the Report
• Follow the current and future North America biobanks market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s Five Forces Analysis.
• Identify the segment that is expected to dominate the market.
• Identify the regions that are expected to witness the fastest growth during the forecast period.
• Identify the latest developments, market shares, and strategies employed by the major market players.
• 3-month analyst support along with the Market Estimate sheet (in Excel).
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
